tiprankstipranks

Amdocs initiated with a Buy at Stifel

Stifel initiated coverage of Amdocs with a Buy rating and $100 price target The firm says Amdocs is a total return story, where the focus is on generating a 10% return for investors through a combination of earnings growth and the dividend yield. Amdocs’ competitive market advantages stem from its product set and software, internal deployment capabilities, and the “significant” managed services area, the analyst tells investors in a research note. Stifel believes the company has the broadest array of software products in the market.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue